Chinese University’s faculty of medicine on Wednesday launched what it described as pioneering technology designed to assess the risk of autism spectrum disorder (ASD) in children.
Developed in collaboration with the CUHK spin-off MicroSigX Biotech Diagnostic, the world’s first “AI-Powered Multikingdom Microbial Biomarkers Technology” aims to enable earlier intervention and support for at-risk families…
阅读更多（Read More）